|
Industry Leaders and Life Sciences Community Recognize IPA 5.0 for New Biomarker and Toxicology Innovations
Redwood City, CA – May
8, 2007 – Ingenuity Systems,
the leading provider of solutions for
the exploration, interpretation, and analysis
of life science information, today announced
that its life sciences knowledge solution,
Ingenuity Pathways Analysis 5.0, won the
“Best in Show” award at CHI’s
Bio-IT World conference and expo held
in Boston last week. IPA was chosen as
the winner in the Life Science Software
& Informatics category, which was
judged by Bio-IT World magazine editors
and highly regarded industry experts,
whose criteria included technical merit,
functionality, and innovation.
“We are delighted to have won this
award,” stated Arthur Okamoto, Senior
Product Manager at Ingenuity. “It is
great recognition of IPA-Biomarker™
and IPA-Tox™, the new capabilities within
the IPA application that enable researchers
to mechanistically connect biomarkers to pathways
of disease and drug response, and elucidate
toxic effects not revealed by traditional
methods. IPA is consistently used by researchers
because it enables them to generate testable
hypotheses, evaluate therapeutic strategies,
and assess toxicity and safety in a straightforward
and reliable manner.”
“A key distinction between IPA 5.0
and other offerings is the unrivaled breadth,
depth, and consistency of the content contained
within the solution”, commented Ramon
Felciano, Chief Technology Officer of Ingenuity
Systems. “When developing IPA 5.0, we
expanded and updated the expert-extracted
content to include new knowledge about diseases,
exogenous and endogenous chemicals, and drugs
and clinical candidates. We are pleased by
this recognition of IPA 5.0, which is a testament
to our ongoing commitment to support our customers
and their research efforts.”
IPA is a software and content solution that
provides unique insights and understanding
of complex biological and chemical systems
at the core of life science research. IPA
is deployed in all major pharmaceutical companies
and at hundreds of biotechnology companies
and academic institutions globally. IPA supports
analysis of data from all experimental platforms
and is used at all stages of the drug discovery
and development process, including target
identification and validation, identification
of biomarkers, predictive toxicology, and
pharmacogenomics.
Trials of Ingenuity Pathways Analysis 5.0
are currently being offered at http://www.ingenuity.com/trial.
For more information about Ingenuity Pathways
Analysis 5.0, please email sales@ingenuity.com
or go to www.ingenuity.com.
About Ingenuity Systems®
Ingenuity enables researchers to model, analyze,
and understand complex biological and chemical
systems foundational to human health and disease.
The Ingenuity products include pathways analysis
software and knowledge bases for life scientists
and bioinformaticians, and enterprise knowledge
management infrastructure, content and services
for leading pharmaceutical and biotech companies.
Ingenuity was founded in 1998 and is headquartered
in Redwood City, California, with offices in
Germany, Switzerland, France, the United Kingdom,
and Japan. www.ingenuity.com.
Contact:
Heidi Bullock
Director, Marketing
Ingenuity Systems
650.381.5150
>
View as PDF 
|
